Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Rd NE, Mail Stop E-52, Atlanta, GA 30333, USA.
Pediatrics. 2009 Dec;124 Suppl 5:S548-57. doi: 10.1542/peds.2009-1542O.
Recent increases in the number and costs of vaccines routinely recommended for children and adolescents have raised concerns about the ability of the current vaccine financing and delivery systems to maintain access to recommended vaccines without financial barriers. Here we review the current state of US financing for vaccine delivery to children and adolescents and identify challenges that should be addressed to ensure future access to routinely recommended vaccines without financial barriers. Challenges were considered from the perspectives of vaccine providers; state and local governments; insurers, employers, and other health care purchasers; vaccine manufacturers; and consumers.
近年来，儿童和青少年常规推荐疫苗的数量和费用不断增加，这引发了人们对当前疫苗融资和提供系统在没有财务障碍的情况下维持获得推荐疫苗的能力的担忧。在这里，我们回顾了美国为向儿童和青少年提供疫苗而进行融资的现状，并确定了为确保未来能够无财务障碍地获得常规推荐疫苗而应解决的挑战。从疫苗提供者、州和地方政府、保险公司、雇主和其他医疗保健购买者、疫苗制造商以及消费者的角度考虑了这些挑战。
